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Abstract
Single nucleotide polymorphisms (SNPs) in the promoter 
region of the IL-1B (interleukin-1) gene have been im-
plicated in a variety of diseases that have an in-
flammatory component. However, there has been sig-
nificant heterogeneity among study results, especially 
between Caucasian and Asian populations. Recently, it 
has been reported that SNPs in the IL-1B gene affect 
transcription, according to haplotype context, and ge-
netic association studies may be more informative if 
functional SNP haplotypes of population are analyzed. 
Therefore, we estimated the distribution of IL-1B pro-
moter haplotypes in 433 Koreans using the three major 
functional IL-1B promoter SNPs (IL-1B-1464, -511, and 
-31) and compared the results with those in Caucasians. 
The difference in IL-1B promoter haplotype frequency 
between Korean and Caucasian populations was stat-
istically significant. The potentially more inflammatory 
haplotypes had higher frequencies in Koreans when 
compared with Caucasians. These Korean haplotype da-
ta will be useful for future association studies between 
IL-1B SNPs and disease risk.
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SNPs in the promoter region of IL-1B gene have been 
implicated in a variety of diseases that have an in-
flammatory component, including cardiovascular dis-
ease, gastric cancer, Alzheimer disease, and periodontal 
disease (Iacoviello et al., 2005; Camargo et al., 2006; 
Griffin et al., 2000; Kornman et al., 1997). The IL-1B 
gene is highly polymorphic, and several SNPs have 
been frequently associated with several diseases 
(Iacoviello et al., 2005; Francis et al, 1999; El-Omar et 
al., 2000). However, there has been significant hetero-
geneity among study results, especially between 
Caucasian and Asian populations (Camargo et al., 2006; 
Lee et al., 2004; Yang et al., 2004; Zeng et al., 2003; 
Chang et al., 2005; Ma et al., 2003; Hodge et al., 2001).
  Recently, Chen et al (Chen et al., 2006) reported that 
SNPs in the IL-1B gene affect transcription according to 
haplotype context, and genetic association studies may 
be more informative if functional SNP haplotypes are 
analyzed, rather than individual functional SNPs. Further, 
they showed that the functional haplotypes differ by 
ethnic population. These findings underlie the relevance 
of population haplotypes in the design of genetic stud-
ies (Chen et al., 2006). In view of these findings, we es-
timated the distribution of IL-1B promoter haplotypes in 
433 Koreans using three major functional IL-1B pro-
moter SNPs (IL-1B-1464, -511, and -31) and compared 
the results with those in Caucasian and African 
populations. Although the IL-1B-3737 polymorphism al-
so had allele-specific differences in nuclear protein bind-
ing, no differences in promoter activity were observed 
with different alleles of this SNP on a background of the 
other SNP sets that showed higher promoter activity 
(Chen et al., 2006). Because it has been suggested that 
the functional significance of IL-1B-3737 might depend 
on a broader haplotype, we used the three SNPs for 
haplotype analysis. Haplotypes were reconstructed by 
PHASE version 2.1, using previously produced genotype 
data (Lee et al., 2004). 
  Of the possible eight haplotypes, three common ones 
accounted for ≥98% of the estimated haplotypes in the 
Korean population. Table 1 shows the haplotype fre-
quency estimation in each population. The potentially 
more inflammatory IL-1B-511T/-31C haplotype repre-
sented 53.5% of the Korean haplotypes, compared with 
33.7% of the Caucasian haplotypes. So far, in many 
previous association studies, the individual SNP ap-
proach, most frequently using IL-1B-511 and IL-1B-31, 
has been adopted. To our knowledge, we reported first 
that the IL-1B-1464 polymorphism has allele-specific dif-
ferences in nuclear protein binding and is associated 
with a clinical disease (Lee et al., 2004). The biological 
implication of this polymorphism was supported by in 
vivo studies by Chen et al. that showed that the 
IL-1B-1464 polymorphism has substantial allele-specific 
effects when both IL-1B-511 and IL-1B-31 were alleles 
T and C, respectively (Chen et al., 2006). The more in-
formative haplotype 1 (GTC), containing the IL-1B-1464 
polymorphism, which shows the highest transcriptional 
activity, represents 9.3% and 6.0% of Korean and 
Caucasian haplotypes, respectively, whereas haplotype 
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Table 1. Common haplotype frequencies of IL1B promoter 
Haplotype
 IL1B-1464/-511/-31
(Transcriptional activity*)
Haplotype frequency (%)
Korean‡
CHB+JPT†
(n=89)
Caucasian*
(n=900)
African*
(n=227)Case
(n=433)
Gastric cancer
(n=331)
Diffuse
(n=188)
Intestinal
(n=133)
GTC (High)
CTC (Intermediate)
GCT (Low)
Total
 9.3 
44.0 
44.8 
98.1 
10.2 
44.2 
44.2 
98.6 
 8.4 
49.7 
40.2 
98.3 
11.9 
37.0 
50.0 
98.9 
10.1 
35.4 
53.9 
99.4 
 6.0 
27.7 
64.8 
98.5 
46.1 
10.6 
42.0 
98.7 
*Data are from Chen et al., 2006. 
†Japanese and Chinese results are from international Hapmap data.
‡Haplotypes were reconstructed using previously produced genotype data from Lee, et al., 2004.
Fig. 1. Population pairwise Fst values for the IL1B pro-
moter region (113.3 Mb, data from Voight et al., 2004.
3 (GCT), with the lowest activity, had a higher frequency 
in Caucasians (64.8%) when compared with Koreans 
(44.2%) (Table 1). The difference in IL-1B promoter hap-
lotype frequency between the Korean and Caucasian 
populations was statistically significant (χ2=20.6, 
p=0.000), and the allele frequencies of the IL-1B-1464 
polymorphism (rs#1143623) were also significantly differ-
ent between the two populations (IL-1B-1464 G allele 
frequencies for Korean and Hapmap European=0.548 
and 0.672, respectively) (χ2=6.38, p=0.01). 
  It has been suggested that genes that are involved in 
immune function may be under selective pressure in di-
rect interaction with the environment (Sawyer et al., 
2004; Kim et al., 2005). The genes that influence a phe-
notypic variation between populations are expected to 
show high Fst values. Compared with the Fst value for 
the Caucasian-vs-Asian comparison, the Fst values for 
the African-vs-Asian or -Caucasian comparisons were 
remarkably high (Fig. 1).
  Previously, we reported that the IL-1B-1464 poly-
morphism contributes to the development of in-
testinal-type gastric cancer among Koreans (Lee et al., 
2004). As a curious finding in our report, the editor 
pointed out that carriers of IL-1B-1464 G tend to have 
a decreased risk of diffuse-type of gastric cancer, which 
is the opposite of intestinal-type gastric cancer, al-
though both intestinal and diffuse types of gastric can-
cer are related to Helicobacter pylori-induced gastritis 
(Furuta et al., 2004). Our results showed that most 
IL-1B-1464 C alleles are linked to the IL-1B-511T/-31C 
haplotype (Table 1). Considering the level of promoter 
activity of haplotype 2 (CTC), we cannot exclude the 
possible association between this haplotype and the risk 
of diffuse-type gastric cancer, especially depending on 
interactions with other regulatory factors (Lee et al., 
2007). Association studies that use individual SNPs ap-
pear to be insufficient, and the understanding of func-
tional haplotype structure of populations could provide 
potential explanations for IL-1B-related controversies 
and ethnic-specific associations. Therefore, we believe 
that these Korean haplotype data will be useful for fu-
ture association studies between IL-1B SNPs and dis-
ease risk.
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